Diabetologia:评估血液线粒体DNA拷贝数与2型糖尿病之间的关系

2022-08-20 从医路漫漫 MedSci原创

多种风险因素与患二型糖尿病病的风险增加有关,包括肥胖、不良生活方式和遗传因素。

背景:以胰岛素抵抗和胰岛素分泌不足相结合为特征的二型糖尿病糖尿病是全球发病率和死亡率的主要原因。多种风险因素与患二型糖尿病病的风险增加有关,包括肥胖、不良生活方式和遗传因素。线粒体以ATP的形式产生细胞对化学能的大部分需求,线粒体功能障碍与二型糖尿病的发展和并发症的各个方面有关,包括胰岛素抵抗、肥胖和β细胞功能障碍。线粒体DNA (mtDNA)是一种环状双链DNA分子,包含37个基因,其中13个基因参与电子传递链和ATP的产生,为细胞提供能量,而其余基因编码的蛋白质参与氨基酸组装成功能蛋白质。虽然线粒体与二型糖尿病的发病有关,但只有少数罕见的mtDNA基因变异与糖尿病有关。MtDNA拷贝数(mtDNA-CN)被认为是线粒体功能的代表。低外周血mtDNA-CN与各种年龄相关疾病有关,包括二型糖尿病、心血管疾病和癌症。在患有肥胖症或二型糖尿病的个体的骨骼肌和脂肪组织中也观察到较低的mtDNA氯化萘。同样,β细胞中较低的mtDNA-CN也与β细胞功能下降有关。

迄今为止,调查mtDNA CN和二型糖尿病之间关系的流行病学研究有限。据我们所知,只有四项队列研究调查了血液mtDNA CN和二型糖尿病之间的联系,其中三项采用前瞻性研究设计[13-16]。四项研究中的两项表明,低血mtDNA-CN与患二型糖尿病病的风险增加有关。然而,这些研究是在相对较小的人群中进行的,2型糖尿病病例(偶发)数量较少,因此糖尿病保证了在更大的研究样本中重复这些发现。此外,这些研究中没有一个研究了血mtDNA和二型糖尿病之间的关系是否是因果关系的问题。

目的:我们使用多变量调整回归分析评估了血液mtDNA CN和二型糖尿病事件之间的联系,使用双向MR评估了血液mtDNA CN和二型糖尿病和身体质量指数之间的联系

方法:采用多变量校正Cox比例风险模型,在285,967名来自英国生物库的无二型糖尿病的无关欧洲个体中,评估血液mtDNACN和二型糖尿病事件之间的关系。此外,进行了一项横断面分析,以调查血液mtDNA-CN和身体质量指数之间的联系。我们还使用双向双样本磁共振成像评估了血液mtDNA-CN与二型糖尿病(图表中N=898,130,FinnGen中N=215,654)和身体质量指数(GIANT中N=681,275)之间的潜在因果关系

结果:在平均11.87年的随访期间,15,111名参与者发展为二型糖尿病。血液mtDNA-CN水平较高的参与者患二型糖尿病的风险较低(HR 0.90 [95% CI 0.89,0.92])。在对身体质量指数和其他混杂因素进行额外调整后,这些结果适度减弱并仍然存在。多变量调整的横断面分析显示,较高的血液mtDNA氯化萘与较低的身体质量指数(0.12 [95%置信区间0.14,0.10]) kg/m2相关。在双向磁共振分析中,我们没有发现mtDNA-CN和二型糖尿病之间,以及mtDNA-CN和身体质量指数之间有因果关系的证据。

表1按mtDNA-中国四分位数分列的人口基线特征

图1 (a)Kaplan–Meier曲线显示了mtDNA-中国四分位数的二型糖尿病事件发生时间。x轴显示以年为单位的随访时间,y轴显示发展为二型糖尿病的总体生存概率。(b)mtDNA-中国四分位数二型糖尿病事件人力资源。模型1针对基因分型批次、主成分1、主成分2、白细胞计数、血小板计数、年龄和性别进行了调整;模型2在模型1的基础上针对身体质量指数进行了额外的调整;基于模型1,模型3还针对身体质量指数、胆固醇药物使用、吸烟状况、身体活动、腰围和二型糖尿病家族史进行了调整

图2 mtDNA-中国(UKB)和二型糖尿病的磁共振结果的森林图。n表示在MR分析中分析的SNP的数量。或表示mtDNA-CN每增加1 SD。二型糖尿病T2D

图3mtDNA-中国(UKB和电荷)和身体质量指数(巨人)磁共振结果的森林图。mtDNA-中国报告了每增加1个标准差的估计值。n表示在MR分析中分析的SNP的数量

图4身体质量指数(巨人)和二型糖尿病(图表)与mtDNA-中国(UKB)相关的磁共振结果的森林图。据报道,在T2D和mtDNA之间的磁共振分析中,估计值为有T2D对没有T2D。根据身体质量指数和mtDNA-中国之间的磁共振分析,身体质量指数报告的估计值为每增加1千克/平方米。n表示在MR分析中分析的SNP的数量。二型糖尿病T2D

结论:本研究的结果表明,观察到的低血mtDNACN和二型糖尿病病高风险之间的联系可能不是因果关系。

原文出处:

Wang W,  Luo J,  Willems van Dijk K, et al.Assessment of the bi-directional relationship between blood mitochondrial DNA copy number and type 2 diabetes mellitus: a multivariable-adjusted regression and Mendelian randomisation study.Diabetologia 2022 Jul 22

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1761990, encodeId=40441e6199014, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Nov 29 21:45:34 CST 2022, time=2022-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804717, encodeId=9aca1804e17a7, content=<a href='/topic/show?id=5b5de757587' target=_blank style='color:#2F92EE;'>#线粒体DN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77575, encryptionId=5b5de757587, topicName=线粒体DN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Thu Mar 09 01:45:34 CST 2023, time=2023-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640223, encodeId=6d39164022379, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jun 25 13:45:34 CST 2023, time=2023-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983935, encodeId=608c19839359f, content=<a href='/topic/show?id=3a375629858' target=_blank style='color:#2F92EE;'>#拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56298, encryptionId=3a375629858, topicName=拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Dec 01 06:45:34 CST 2022, time=2022-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419799, encodeId=ba6d1419e99c5, content=<a href='/topic/show?id=1617e7576fd' target=_blank style='color:#2F92EE;'>#线粒体DNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77576, encryptionId=1617e7576fd, topicName=线粒体DNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427c3531901, createdName=jambiya, createdTime=Sun Aug 21 08:45:34 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784637, encodeId=1c691e846370f, content=<a href='/topic/show?id=bfcb6102f0' target=_blank style='color:#2F92EE;'>#DNA拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6102, encryptionId=bfcb6102f0, topicName=DNA拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b3e473, createdName=pyaili, createdTime=Sun Sep 25 09:45:34 CST 2022, time=2022-09-25, status=1, ipAttribution=)]
    2022-11-29 docwu2019
  2. [GetPortalCommentsPageByObjectIdResponse(id=1761990, encodeId=40441e6199014, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Nov 29 21:45:34 CST 2022, time=2022-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804717, encodeId=9aca1804e17a7, content=<a href='/topic/show?id=5b5de757587' target=_blank style='color:#2F92EE;'>#线粒体DN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77575, encryptionId=5b5de757587, topicName=线粒体DN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Thu Mar 09 01:45:34 CST 2023, time=2023-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640223, encodeId=6d39164022379, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jun 25 13:45:34 CST 2023, time=2023-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983935, encodeId=608c19839359f, content=<a href='/topic/show?id=3a375629858' target=_blank style='color:#2F92EE;'>#拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56298, encryptionId=3a375629858, topicName=拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Dec 01 06:45:34 CST 2022, time=2022-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419799, encodeId=ba6d1419e99c5, content=<a href='/topic/show?id=1617e7576fd' target=_blank style='color:#2F92EE;'>#线粒体DNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77576, encryptionId=1617e7576fd, topicName=线粒体DNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427c3531901, createdName=jambiya, createdTime=Sun Aug 21 08:45:34 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784637, encodeId=1c691e846370f, content=<a href='/topic/show?id=bfcb6102f0' target=_blank style='color:#2F92EE;'>#DNA拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6102, encryptionId=bfcb6102f0, topicName=DNA拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b3e473, createdName=pyaili, createdTime=Sun Sep 25 09:45:34 CST 2022, time=2022-09-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1761990, encodeId=40441e6199014, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Nov 29 21:45:34 CST 2022, time=2022-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804717, encodeId=9aca1804e17a7, content=<a href='/topic/show?id=5b5de757587' target=_blank style='color:#2F92EE;'>#线粒体DN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77575, encryptionId=5b5de757587, topicName=线粒体DN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Thu Mar 09 01:45:34 CST 2023, time=2023-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640223, encodeId=6d39164022379, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jun 25 13:45:34 CST 2023, time=2023-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983935, encodeId=608c19839359f, content=<a href='/topic/show?id=3a375629858' target=_blank style='color:#2F92EE;'>#拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56298, encryptionId=3a375629858, topicName=拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Dec 01 06:45:34 CST 2022, time=2022-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419799, encodeId=ba6d1419e99c5, content=<a href='/topic/show?id=1617e7576fd' target=_blank style='color:#2F92EE;'>#线粒体DNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77576, encryptionId=1617e7576fd, topicName=线粒体DNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427c3531901, createdName=jambiya, createdTime=Sun Aug 21 08:45:34 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784637, encodeId=1c691e846370f, content=<a href='/topic/show?id=bfcb6102f0' target=_blank style='color:#2F92EE;'>#DNA拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6102, encryptionId=bfcb6102f0, topicName=DNA拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b3e473, createdName=pyaili, createdTime=Sun Sep 25 09:45:34 CST 2022, time=2022-09-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1761990, encodeId=40441e6199014, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Nov 29 21:45:34 CST 2022, time=2022-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804717, encodeId=9aca1804e17a7, content=<a href='/topic/show?id=5b5de757587' target=_blank style='color:#2F92EE;'>#线粒体DN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77575, encryptionId=5b5de757587, topicName=线粒体DN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Thu Mar 09 01:45:34 CST 2023, time=2023-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640223, encodeId=6d39164022379, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jun 25 13:45:34 CST 2023, time=2023-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983935, encodeId=608c19839359f, content=<a href='/topic/show?id=3a375629858' target=_blank style='color:#2F92EE;'>#拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56298, encryptionId=3a375629858, topicName=拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Dec 01 06:45:34 CST 2022, time=2022-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419799, encodeId=ba6d1419e99c5, content=<a href='/topic/show?id=1617e7576fd' target=_blank style='color:#2F92EE;'>#线粒体DNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77576, encryptionId=1617e7576fd, topicName=线粒体DNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427c3531901, createdName=jambiya, createdTime=Sun Aug 21 08:45:34 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784637, encodeId=1c691e846370f, content=<a href='/topic/show?id=bfcb6102f0' target=_blank style='color:#2F92EE;'>#DNA拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6102, encryptionId=bfcb6102f0, topicName=DNA拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b3e473, createdName=pyaili, createdTime=Sun Sep 25 09:45:34 CST 2022, time=2022-09-25, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1761990, encodeId=40441e6199014, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Nov 29 21:45:34 CST 2022, time=2022-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804717, encodeId=9aca1804e17a7, content=<a href='/topic/show?id=5b5de757587' target=_blank style='color:#2F92EE;'>#线粒体DN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77575, encryptionId=5b5de757587, topicName=线粒体DN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Thu Mar 09 01:45:34 CST 2023, time=2023-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640223, encodeId=6d39164022379, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jun 25 13:45:34 CST 2023, time=2023-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983935, encodeId=608c19839359f, content=<a href='/topic/show?id=3a375629858' target=_blank style='color:#2F92EE;'>#拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56298, encryptionId=3a375629858, topicName=拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Dec 01 06:45:34 CST 2022, time=2022-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419799, encodeId=ba6d1419e99c5, content=<a href='/topic/show?id=1617e7576fd' target=_blank style='color:#2F92EE;'>#线粒体DNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77576, encryptionId=1617e7576fd, topicName=线粒体DNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427c3531901, createdName=jambiya, createdTime=Sun Aug 21 08:45:34 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784637, encodeId=1c691e846370f, content=<a href='/topic/show?id=bfcb6102f0' target=_blank style='color:#2F92EE;'>#DNA拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6102, encryptionId=bfcb6102f0, topicName=DNA拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b3e473, createdName=pyaili, createdTime=Sun Sep 25 09:45:34 CST 2022, time=2022-09-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1761990, encodeId=40441e6199014, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Nov 29 21:45:34 CST 2022, time=2022-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804717, encodeId=9aca1804e17a7, content=<a href='/topic/show?id=5b5de757587' target=_blank style='color:#2F92EE;'>#线粒体DN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77575, encryptionId=5b5de757587, topicName=线粒体DN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Thu Mar 09 01:45:34 CST 2023, time=2023-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640223, encodeId=6d39164022379, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jun 25 13:45:34 CST 2023, time=2023-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983935, encodeId=608c19839359f, content=<a href='/topic/show?id=3a375629858' target=_blank style='color:#2F92EE;'>#拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56298, encryptionId=3a375629858, topicName=拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Dec 01 06:45:34 CST 2022, time=2022-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419799, encodeId=ba6d1419e99c5, content=<a href='/topic/show?id=1617e7576fd' target=_blank style='color:#2F92EE;'>#线粒体DNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77576, encryptionId=1617e7576fd, topicName=线粒体DNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427c3531901, createdName=jambiya, createdTime=Sun Aug 21 08:45:34 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784637, encodeId=1c691e846370f, content=<a href='/topic/show?id=bfcb6102f0' target=_blank style='color:#2F92EE;'>#DNA拷贝数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6102, encryptionId=bfcb6102f0, topicName=DNA拷贝数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b3e473, createdName=pyaili, createdTime=Sun Sep 25 09:45:34 CST 2022, time=2022-09-25, status=1, ipAttribution=)]

相关资讯

Saudi Pharm J:2型糖尿病降糖药物的处方模式及其影响因素

二甲双胍是最常用的一线药物,西格列汀是最常用的二线药物,其次是格列齐特、格列本脲和格列美脲。

Front Endocrinol:磺脲类降糖药与2型糖尿病患者的患癌风险

糖化血红蛋白(HbA1c),一种广泛使用的血糖控制指标,是T2DM启用和调整用药的一个重要预测因素。

Cardiovasc Diabetol:使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险

糖尿病与房颤密切相关,它们的共存与心血管不良事件、心力衰竭住院、发病率和死亡率的重大风险相关。

PLoS One:不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病风险评分的影响

磺酰脲类药物组合显示出LDL和甘油三酯值的显著降低。

《中国老年2型糖尿病防治临床指南(2022年版)》解读

《中国老年2型糖尿病防治临床指南(2022年版)》汇总了国内外老年糖尿病相关研究信息,为优化我国老年糖尿病防治理念、促进临床诊疗规范化、提高老年糖尿病总体管理水平提供了循证医学证据。

磺脲类药物可增加2型糖尿病患者的癌症风险?最新研究答案是“No”!

磺脲类药物和二甲双胍是最常用的糖尿病药物,占研究人群中所有GLD的64%,而与其他GLD相比,研究发现磺酰脲类药物的使用与癌症风险无关。